Table 2: Baseline, 2, 4 and 6 months parameters.
| Parameters (20 patients) | Baseline | 2 months | 4 months | 6 months |
| Hemoglobin (g/dl) | 10.7 ± 1 | 11.2 ± 1 | 11.5 ± 1.3* | 11.2 ± 1.1* |
| Hematocrit (%) | 33 ± 3 | 35 ± 4* | 35 ± 4* | 34 ± 4 |
| Ferritin (ng/ml) | 242 ± 122 | 485 ± 105** | 406 ± 165** | 462 ± 252** |
| TSAT (%) | 20 ± 8 | 28 ± 11** | 34 ± 16** | 30 ± 8** |
| Transferrin (mg/dl) | 190 ± 29 | 171 ± 31** | 178 ± 33** | 179 ± 39* |
| PAP (U/L) | 178 ± 297 | 115 ± 59 | 109 ± 56 | 104 ± 47 |
| GGT ((U/L) | 55 ± 99 | 51 ± 72 | 53 ± 81 | 46 ± 51 |
| ASAT (U/L) | 17 ± 8 | 19 ± 9 | 18.5 ± 6 | 18 ± 10 |
| ALAT (U/L) | 20 ± 11 | 24 ± 25 | 22 ± 12 | 20 ± 13 |
| PTH (pg/ml) | 333 ± 270 | 256 ± 185 | 270 ± 181 | 245 ± 160 |
| Serum calcium (mg/dl) | 8.9 ± 0.8 | 8.9 ± 0.5 | 8.9 ± 0.7 | 8.9 ± 0.6 |
| Serum phosphorus (mg/dl) | 5.1 ± 1.5 | 4.7 ± 1.4 | 4.7 ± 1.1 | 4.7 ± 1.2 |
| Doses of ESA (mcg/week) | 20 ± 18 | 15 ± 10 | 16 ± 11 | 16 ± 12 |
TSAT: Transferrin saturation; PAP: Plasma alkaline phosphatase; GGT: Gamma-glutamyl transpeptidase; ASAT: Aspartyl aminotransferase; ALAT: Alanine aminotransferase; PTH: Parathyroid hormone; ESA: Erythropoiesis-stimulating agent.
*P < 0.05; **P < 0.01, statistical significance.